Pernix Therapeutics Holdings, Inc.
10 North Park Place, Suite 201
Morristown, New Jersey 07960
December 15, 2017
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Pernix Therapeutics Holdings, Inc.
Registration Statement on Form S-3
Filed November 22, 2017
File No. 333-221717
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Pernix Therapeutics Holdings, Inc. (the "Company") hereby requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3 and declare such Registration Statement effective as of 4:00 p.m., Eastern Standard Time, on December 18, 2017, or as soon thereafter as possible.
Please feel free to direct any questions or comments concerning this request to Steve Abrams of Hogan Lovells US LLP at (267) 675-4671.
Very truly yours, |
Pernix Therapeutics Holdings, Inc. |
/s/ John Sedor | ||
By: |
| John Sedor |
Title: |
| Chief Executive Officer |
